Scinovex
article Open AccessTop 1% cited

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Annals of Oncology · 2011 · Vol. 22(8) · pp. 1736–1747
Aron GoldhirschW. C. WoodAlan S. CoatesRichard D. GelberBeat ThürlimannHans-Jörg Senn
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchBreast Lesions and CarcinomasMedicineTrastuzumabBreast cancerOncologySystemic therapyDiseaseInternal medicineCancerRadiation therapyTargeted therapy

MeSH terms

TrastuzumabAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsBreast NeoplasmsConsensus Development Conferences as TopicConsensus Statements as TopicFemaleHumansNeoplasm StagingChemotherapy, AdjuvantDisease-Free SurvivalReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesAntineoplastic Agents, Hormonal

Funding

  • Amgen
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Genomic Health
  • Università degli Studi di Milano
  • Ipsen
  • Genentech
  • Winship Cancer Institute
  • National Cancer Institute
Citations
3,850
FWCI
110.70
field-weighted impact
References
99
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.